Here’s what you should know:
1. Researchers analyzed 1,058 individuals with colon cancer.
2. The patients agreed to have blood drawn for research.
3. Researchers performed germline testing on all individuals using a 25-gene panel to look for inherited mutations associated with cancer risk.
4. Researchers found that inherited mutations were identified in nearly 10 percent of individuals analyzed with the 25-gene panel.
Researchers said that number “was higher than what we would have expected in the past.”
The researchers concluded that there might be a link between mutations in those genes and CRC risk.
More articles on gastroenterology:
Bowel cancer mortality rates drop 30% — 4 study insights
GI leader to know: Dr. Louis Leite of Pennsylvania Gastroenterology
2 new GI-driven ASCs & facilities — March 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
